Fennec Provides Corporate Update and Announces Third Quarter 2016 Results
November 14, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Nov. 14, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec Announces Update of SIOPEL 6 Study on Sodium Thiosulfate (STS) Presented at the International Society of Paediatric Oncology (SIOP) 2016 Meeting
October 24, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Oct. 24, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec to Present at Rodman & Renshaw 18th Annual Global Investment Conference in New York on September 13, 2016
September 08, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Sept. 8, 2016) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF) today announced that Rosty Raykov, CEO of Fennec, will present...
Fennec Provides Corporate Update and Announces Second Quarter 2016 Results
August 12, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Aug. 12, 2016) -
SIOPEL 6 interim results presented in oral presentation at ASCO 2016 confirms no...
Fennec Announces Appointment of Marco Brughera to the Board of Directors
August 11, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Aug. 11, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference in New York on July 13, 2016
July 06, 2016 05:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - July 6, 2016) - Fennec Pharmaceuticals, Inc. (TSX:FRX) (OTCQB:FENCF), today announced that the Company will present at the Cantor...
Fennec Announces Results of Annual Meeting
June 08, 2016 17:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - June 8, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today announced that the nominees listed in the management proxy...
Fennec Announces Interim Results of SIOPEL 6 Study on Sodium Thiosulfate (STS) Presented at the American Association of Clinical Oncology (ASCO) 2016 Meeting
June 06, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - June 6, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development of...
Fennec Announces Upcoming Events and Presentations
May 18, 2016 17:44 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 18, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) (the "Company" or "Fennec"), a specialty pharmaceutical company...
Fennec Announces Second Closing of Private Placement
May 16, 2016 11:49 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 16, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) (the "Company" or "Fennec"), a specialty pharmaceutical company...